Trends in Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry.

ABSTRACT:

Importance

Although transcatheter aortic valve replacement (TAVR) outcomes in the US have improved substantially since 2011, it is unknown whether these trends have continued since 2019.

Objective

To examine changes in risk-adjusted TAVR outcomes from 2019 to 2022 and to examine any noteworthy trends over time.

Design, setting, and participants

This cohort study examined data from patients with severe aortic stenosis treated with TAVR at 786 US hospitals between January 1, 2019, and March 31, 2022, included in the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapies (TVT) Registry.

Exposure

Patients who underwent TAVR.

Main outcomes and measures

The primary outcome was 30-day mortality, and the secondary o

SUBMITTER: Arnold SV 

PROVIDER: S-EPMC11581560 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature